Background
Acute Respiratory Distress Syndrome (ARDS) remains a significant cause of morbidity and mortality in critically ill patients. Mechanical ventilation is a cornerstone of ARDS management, with lung-protective strategies emphasizing low tidal volumes and limited plateau pressures to prevent ventilator-induced lung injury (VILI) [1,2]. However, the presence of obesity profoundly alters respiratory mechanics, complicating the application of standard ventilatory targets. Increased chest wall elastance, reduced functional residual capacity, and atelectasis are common in obese patients, potentially leading to misinterpretation of airway pressures and suboptimal ventilation strategies [3,4]. This clinical scenario often necessitates a nuanced approach to ventilator settings, particularly concerning pressure targets and the judicious use of adjunctive therapies.
Methods
This paper synthesizes expert opinions derived from a structured clinical question-and-answer discussion forum among critical care physicians. The discussion focused on a hypothetical 55-year-old obese female (BMI 38) with moderate ARDS (P/F ratio 142) secondary to aspiration pneumonitis, managed with volume-controlled ventilation (tidal volume 6 mL/kg PBW, PEEP 14 cmH2O, respiratory rate 24 breaths/min, FiO2 0.7), exhibiting a plateau pressure of 28 cmH2O and a driving pressure of 14 cmH2O. Key questions addressed included the tolerability of higher plateau pressures in obese patients, the primary ventilator target (driving pressure vs. plateau pressure), timing of prone positioning, and the role of esophageal balloon manometry. Responses from three critical care specialists (Pulmonology, Pulmonary & Critical Care, Anesthesiology & Pain Medicine) were analyzed, consolidated, and integrated with current evidence from landmark clinical trials and guidelines to formulate a comprehensive academic review.
Results
Expert consensus indicated a willingness to tolerate higher plateau pressures (up to 33-35 cmH2O) in obese ARDS patients, provided the driving pressure remained below 15 cmH2O. This approach acknowledges the substantial contribution of chest wall elastance to total airway pressure in obesity, suggesting that transpulmonary pressure, the true determinant of lung stress, may be lower than indicated by plateau pressure alone. Driving pressure was identified as the primary ventilator target, consistent with meta-analytic data demonstrating its strong association with mortality [5]. Early prone positioning was advocated for eligible patients (P/F < 150 with PEEP ≥ 5 cmH2O), with specific emphasis on its enhanced mechanical benefits in obese individuals and practical considerations for safe implementation [6]. The routine use of esophageal balloon manometry was strongly recommended in all obese ARDS patients to guide individualized PEEP titration and assess transpulmonary pressure, despite mixed results from large trials regarding overall mortality benefit, citing potential subgroup benefits in high chest wall elastance patients [7].
Conclusions
Effective mechanical ventilation in obese patients with moderate ARDS requires a personalized strategy that accounts for altered respiratory mechanics. This expert consensus highlights the importance of prioritizing driving pressure as a primary ventilatory target and considering transpulmonary pressure via esophageal manometry to guide PEEP titration, allowing for potentially higher plateau pressures when chest wall elastance is elevated. Early implementation of prone positioning, with meticulous attention to logistical challenges, is a critical adjunctive therapy. These recommendations underscore a shift towards a more physiological, individualized approach to lung-protective ventilation, aiming to minimize VILI and improve outcomes in this challenging patient population.
Acute Respiratory Distress Syndrome (ARDS) is a severe form of acute lung injury characterized by diffuse alveolar damage, hypoxemia, and reduced lung compliance [8]. Despite significant advancements in critical care, ARDS continues to carry a high mortality rate, necessitating meticulous management strategies [9]. Mechanical ventilation, while life-saving, can exacerbate lung injury if not carefully managed, leading to ventilator-induced lung injury (VILI) [10]. The seminal ARDSNet trial established the cornerstone of lung-protective ventilation, advocating for low tidal volumes (6 mL/kg predicted body weight) and limiting plateau pressures to less than 30 cmH2O [1].
The global prevalence of obesity has steadily increased, presenting a growing challenge in critical care settings. Obese patients admitted to intensive care units (ICUs) often exhibit altered respiratory mechanics, including reduced functional residual capacity, increased abdominal pressure, and higher chest wall elastance [3,4]. These physiological changes can significantly complicate the application of standard lung-protective ventilation strategies in ARDS. The increased chest wall elastance in obese individuals means that a greater proportion of the measured airway pressure is dissipated across the chest wall, rather than being transmitted to the lung parenchyma [11]. Consequently, a plateau pressure that might be considered safe in a non-obese patient could represent a lower, potentially protective, transpulmonary pressure in an obese patient, or conversely, a seemingly acceptable plateau pressure could mask injurious transpulmonary pressures if PEEP is set too low.
This complex interplay between obesity, ARDS pathophysiology, and mechanical ventilation parameters necessitates a refined approach to ventilator management. Clinicians frequently grapple with questions regarding the optimal balance between maintaining lung protection and ensuring adequate gas exchange, especially when conventional pressure targets are difficult to achieve. The emergence of new physiological targets, such as driving pressure and transpulmonary pressure, has further nuanced these discussions, prompting a re-evaluation of established practices [5,7].
This paper aims to synthesize expert clinical perspectives on key challenges in mechanically ventilating obese patients with moderate ARDS. By integrating expert consensus with current evidence, we seek to provide practical guidance on setting ventilatory targets, utilizing adjunctive therapies like prone positioning, and incorporating advanced monitoring techniques such as esophageal manometry. The objective is to delineate a contemporary, evidence-informed framework for optimizing lung protection and improving patient outcomes in this challenging clinical population.
In obese patients with moderate Acute Respiratory Distress Syndrome, what are the optimal targets for mechanical ventilation, specifically concerning plateau pressure and driving pressure, and what is the role and timing of adjunctive therapies such as prone positioning and esophageal balloon manometry?
This academic paper was developed by transforming a physician-to-physician clinical Q&A discussion, originally hosted on a specialized medical forum, into a formal research article. The initial clinical scenario involved a 55-year-old obese female (BMI 38) with moderate ARDS (P/F ratio 142) on volume-controlled ventilation, presenting with specific ventilator parameters (TV 320 mL, PEEP 14, RR 24, FiO2 0.7, Plateau pressure 28 cmH2O, Driving pressure 14 cmH2O).
The original discussion posed four critical questions to a community of critical care specialists. Three expert physicians, specializing in Pulmonology, Pulmonary & Critical Care, and Anesthesiology & Pain Medicine, provided detailed responses. These responses, including the 'accepted answer' and a highly-voted contributing answer, formed the primary source material for this synthesis. The methodology involved a systematic review and consolidation of these expert opinions, identifying areas of consensus and specific recommendations.
To enhance the academic rigor and clinical applicability, the expert consensus was cross-referenced and integrated with established medical literature, including landmark clinical trials, systematic reviews, and international guidelines relevant to ARDS management, obesity, and mechanical ventilation. Specific trials referenced include ARDSNet [1], Amato et al. 2015 [5], PROSEVA [6], and EPVent-2 [7]. The transformation process involved structuring the discussion into a formal academic paper format, employing formal academic prose, ensuring medical accuracy, and adhering to Vancouver citation style. The aim was to create a comprehensive, evidence-informed document suitable for dissemination as a preprint, reflecting contemporary best practices in managing ARDS in obese patients.
The expert consensus provided comprehensive guidance on the nuanced management of mechanical ventilation in obese patients with moderate ARDS, addressing key challenges related to pressure targets and adjunctive therapies. The discussion highlighted a significant shift in clinical practice, emphasizing physiological rather than purely numerical targets.
1. Plateau Pressure in Obese Patients: A key finding was the recommendation to tolerate higher plateau pressures, specifically up to 33 to 35 cmH2O, in obese patients, provided that the driving pressure remains below 15 cmH2O. This recommendation stems from the understanding that in obese individuals, a substantial portion of the measured airway pressure is expended in overcoming increased chest wall elastance, which is attributed to the pressure exerted by abdominal contents on the diaphragm [11,12]. Consequently, the transpulmonary pressure (Ptp), which represents the pressure distending the lung parenchyma and is directly correlated with VILI, may be significantly lower than the measured plateau pressure (Pplat). For instance, in a patient with a BMI of 38, chest wall elastance could contribute 8 to 12 cmH2O to the total plateau pressure, implying that a Pplat of 33 cmH2O might correspond to a Ptp of 21-25 cmH2O, which could be within a safe range for lung parenchyma [13]. This approach challenges the strict adherence to the <30 cmH2O plateau pressure limit established by ARDSNet, advocating for a more individualized interpretation in the context of altered chest wall mechanics [1].
2. Driving Pressure as a Primary Ventilator Target: There was a strong consensus that driving pressure (Pplat - PEEP) has become the primary ventilator target, superseding plateau pressure in clinical practice. This shift is largely influenced by the meta-analysis by Amato et al. (2015), which identified driving pressure as the strongest predictor of mortality in ARDS, even when plateau pressure was within acceptable limits [5]. The study demonstrated that each 1 cmH2O increase in driving pressure above 15 cmH2O was associated with a significant increase in mortality. Experts now primarily target a driving pressure of less than 14 cmH2O, utilizing plateau pressure as a secondary safety check. The rationale is that driving pressure reflects the cyclic stretch applied to the lung parenchyma, which is a more direct determinant of VILI than absolute airway pressures [14]. Maintaining a low driving pressure aims to minimize cyclic strain and stress on the lung, thereby reducing the risk of barotrauma and volutrauma.
3. Timing and Role of Prone Positioning: Early prone positioning was strongly advocated for patients meeting criteria (P/F ratio < 150 with PEEP ≥ 5 cmH2O), aligning with the findings of the PROSEVA trial [6]. The PROSEVA trial demonstrated a significant mortality benefit for early and prolonged prone positioning in severe ARDS. In obese patients, prone positioning is considered particularly beneficial, as it can improve respiratory mechanics more effectively than in non-obese individuals by offloading the abdominal contents from the dorsal lung regions, leading to improved ventilation-perfusion matching and recruitment of atelectatic areas [15]. Specific practical considerations for prone positioning in obese patients were highlighted, including the use of a 'swimming' prone position with gel rolls to allow the abdomen to hang freely, which further enhances mechanical improvements. Crucial precautions include ensuring adequate staffing (minimum 5 people for patients > 120 kg), meticulous pressure point mapping to prevent skin breakdown, impeccable endotracheal tube (ETT) fixation to prevent accidental extubation, and considering neuromuscular blockade for the initial 12-24 hours to facilitate safe positioning and prevent patient-ventilator asynchrony or self-extubation [16].
4. Role of Esophageal Balloon Manometry: The routine use of esophageal balloon manometry for measuring transpulmonary pressure was strongly recommended in every obese patient with ARDS, if available. This technique allows for the direct measurement of transpulmonary pressure by subtracting esophageal pressure (a surrogate for pleural pressure) from airway pressure, thereby distinguishing between lung and chest wall contributions to total pressure [13]. While the EPVent-2 trial did not demonstrate an overall mortality benefit for esophageal pressure-guided ventilation, subgroup analyses suggested potential benefits in patients with high chest wall elastance, precisely the population of obese ARDS patients [7]. By providing a more accurate assessment of lung stress, esophageal manometry enables individualized PEEP titration, preventing both atelectrauma (from insufficient PEEP) and overdistension (from excessive PEEP), ultimately leading to a more personalized and lung-protective ventilation strategy [17].
| Approach | Evidence Level | Key Advantages | Limitations | Source |
|---|---|---|---|---|
| Tolerating Higher Plateau Pressure in Obesity | Expert Consensus, Physiological Rationale | Accounts for increased chest wall elastance; avoids under-ventilation; targets true lung stress (transpulmonary pressure) | Requires careful monitoring of driving pressure; potential for misinterpretation without esophageal manometry | Expert Consensus, [11,12] |
| Driving Pressure Targeting (<14-15 cmH2O) | High (Meta-analysis) | Strongest predictor of mortality; reflects cyclic lung strain; guides PEEP and TV adjustments | Does not directly measure transpulmonary pressure; still influenced by chest wall mechanics | Amato et al. 2015 [5] |
| Early Prone Positioning (P/F < 150) | High (RCT) | Improves oxygenation and mortality; enhances mechanics in obesity by offloading abdomen; recruits dorsal lung | Logistically challenging in obese patients; requires significant staffing and meticulous care; risk of complications (e.g., ETT dislodgement) | PROSEVA 2013 [6], Expert Consensus |
| Esophageal Balloon Manometry | Moderate (RCT subgroup analysis, Physiological Rationale) | Directly measures transpulmonary pressure; enables personalized PEEP titration; differentiates lung vs. chest wall elastance | Requires specialized equipment and expertise; EPVent-2 showed no overall mortality benefit (potential subgroup benefit) | EPVent-2 2020 [7], Expert Consensus |
| 'Swimming' Prone Position in Obesity | Expert Consensus, Physiological Rationale | Further unloads abdominal contents; potentially greater improvement in mechanics than standard prone | Increased complexity; higher risk of pressure injuries if not meticulously performed | Expert Consensus |
| Neuromuscular Blockade for Prone Positioning | Moderate (Physiological Rationale, Practical Experience) | Prevents self-extubation; reduces patient-ventilator asynchrony; facilitates safe positioning | Potential for prolonged weakness; masks neurological changes | Expert Consensus, [16] |
The management of ARDS in obese patients presents a formidable challenge, necessitating a departure from a 'one-size-fits-all' approach to mechanical ventilation. The expert consensus synthesized in this paper underscores a critical shift towards individualized, physiology-guided strategies that prioritize the true determinants of ventilator-induced lung injury (VILI), namely lung stress and strain, over absolute airway pressure measurements alone. This paradigm shift is particularly pertinent in obesity, where altered chest wall mechanics significantly confound the interpretation of conventional ventilatory parameters.
Historically, the ARDSNet trial established the importance of limiting plateau pressure to <30 cmH2O as a cornerstone of lung-protective ventilation [1]. However, this threshold was primarily derived from studies in non-obese populations. In obese patients, the elevated chest wall elastance means that a substantial portion of the measured plateau pressure is transmitted to the chest wall rather than the lung parenchyma [11,12]. Therefore, rigidly adhering to the <30 cmH2O limit without considering transpulmonary pressure could lead to under-ventilation, hypoxemia, and failure to adequately recruit atelectatic lung regions, potentially exacerbating lung injury. The expert recommendation to tolerate plateau pressures up to 33-35 cmH2O, provided driving pressure is controlled, reflects a more nuanced understanding of lung mechanics in this population, aiming to achieve optimal lung distension without overstretching the parenchyma.
The emphasis on driving pressure as the primary ventilator target represents a significant evolution in ARDS management. The meta-analysis by Amato et al. (2015) provided compelling evidence that driving pressure, which reflects the cyclic stretch applied to the lung, is a more robust predictor of mortality than tidal volume or plateau pressure alone [5]. This finding has profound implications for clinical practice, guiding clinicians to prioritize minimizing the difference between plateau pressure and PEEP, even if it means adjusting tidal volume or PEEP. The goal is to reduce dynamic strain on the lung, thereby mitigating VILI. This principle is universally applicable but gains particular importance in obese patients, where the risk of VILI is amplified due to heterogeneous lung aeration and increased mechanical stress.
Adjunctive therapies, particularly prone positioning, are crucial in optimizing outcomes in ARDS. The PROSEVA trial unequivocally demonstrated a mortality benefit for early and prolonged prone positioning in severe ARDS [6]. In obese patients, the benefits of prone positioning are often amplified. By shifting the weight of the abdominal contents off the diaphragm and dorsal lung regions, prone positioning can significantly improve lung mechanics, reduce atelectasis, and enhance ventilation-perfusion matching [15]. The practical considerations for proning obese patients, including adequate staffing, meticulous pressure area care, and secure ETT fixation, are not merely logistical but are essential for patient safety and successful implementation. The 'swimming' prone position, as suggested by one expert, further refines this technique by maximizing abdominal decompression, potentially leading to even greater improvements in respiratory mechanics.
Finally, the strong recommendation for routine esophageal balloon manometry in obese ARDS patients highlights the growing recognition of personalized ventilation. While the EPVent-2 trial did not show an overall mortality benefit, its subgroup analysis suggested potential benefits in patients with high chest wall elastance, precisely the characteristic of obese individuals [7]. Esophageal manometry provides a direct, physiological measurement of transpulmonary pressure, allowing clinicians to titrate PEEP to achieve optimal lung recruitment and avoid both collapse and overdistension [13,17]. This precision is invaluable in obese patients, where conventional PEEP titration strategies based solely on oxygenation or static compliance may be misleading. By guiding PEEP based on transpulmonary pressure, clinicians can ensure that the lung parenchyma receives appropriate distending pressure, thereby minimizing VILI and optimizing gas exchange. The integration of these advanced monitoring techniques, coupled with a nuanced understanding of respiratory mechanics in obesity, represents the forefront of lung-protective ventilation strategies.
This paper's strengths lie in its synthesis of expert clinical opinions from a specialized medical discussion forum, providing practical, real-world insights into the management of a challenging patient population. The consensus reflects the collective experience of critical care specialists, integrating current evidence from landmark trials with practical considerations. The focus on a specific clinical scenario (obese patient with moderate ARDS) allows for highly relevant and actionable recommendations, addressing common dilemmas faced by intensivists. Furthermore, the integration of established literature strengthens the evidence base for the expert recommendations.
However, several limitations must be acknowledged. Firstly, this paper is based on a limited number of expert opinions (three contributing physicians) and does not represent a formal, large-scale consensus conference. While the opinions are from highly experienced specialists, the scope is inherently narrower than a multi-center study or a guideline developed by a large professional society. Secondly, the source material is a clinical Q&A discussion, which, while valuable for practical insights, is not a randomized controlled trial or a systematic review. The recommendations, therefore, carry a level of evidence derived from expert opinion and physiological rationale, supported by existing literature, rather than de novo clinical trial data. Lastly, the generalizability of these recommendations may vary depending on resource availability (e.g., esophageal manometry) and local expertise in different healthcare settings.
The optimal mechanical ventilation strategy for obese patients with moderate ARDS necessitates a personalized approach that transcends conventional, generalized targets. This expert consensus highlights the critical importance of prioritizing driving pressure as the primary ventilatory target (<14-15 cmH2O) and judiciously tolerating higher plateau pressures (up to 33-35 cmH2O) when elevated chest wall elastance is a factor. Early and meticulous prone positioning is an indispensable adjunctive therapy, offering enhanced mechanical benefits in obese individuals. Furthermore, the routine use of esophageal balloon manometry is strongly advocated to guide individualized PEEP titration and ensure lung-protective ventilation by directly assessing transpulmonary pressure.
These recommendations underscore a contemporary shift towards a physiology-guided approach, emphasizing the true determinants of lung stress and strain. By integrating advanced monitoring techniques with evidence-based adjunctive therapies, clinicians can optimize lung protection, mitigate ventilator-induced lung injury, and ultimately improve outcomes in the challenging cohort of obese patients with ARDS. Future research should continue to explore the efficacy of personalized ventilation strategies, particularly in diverse obese populations and across various healthcare settings.
Conceptualization: Dr. Suresh Kumar (Question Author). Data Curation: Editor-in-Chief. Formal Analysis: Editor-in-Chief. Investigation: Dr. Rajesh Iyer, Dr. Vikram Singh. Methodology: Editor-in-Chief. Project Administration: Editor-in-Chief. Resources: Dr. Suresh Kumar, Dr. Rajesh Iyer, Dr. Vikram Singh. Software: Not applicable. Supervision: Editor-in-Chief. Validation: Editor-in-Chief. Visualization: Editor-in-Chief. Writing – Original Draft Preparation: Editor-in-Chief. Writing – Review & Editing: Editor-in-Chief, Dr. Suresh Kumar, Dr. Rajesh Iyer, Dr. Vikram Singh.
The authors declare no conflicts of interest. The contributing physicians provided their expert opinions as part of a clinical discussion forum without financial incentive related to this publication.
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The transformation of the clinical discussion into an academic paper was performed as an editorial initiative.
Dr. Suresh Kumar, Dr. Rajesh Iyer, Dr. Vikram Singh. "Optimizing Mechanical Ventilation in Obese Patients with Moderate Acute Respiratory Distress Syndrome: A Consensus-Based Approach to Driving Pressure, Plateau Pressure, and Adjunctive Therapies." tachyDx Research, TDX-2026-00014, April 6, 2026. https://www.tachydx.com/research/TDX-2026-00014
This paper is indexed in the tachyDx Research Registry. DOI registration pending.
License: This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this material for any purpose, provided appropriate credit is given.
Disclaimer: tachyDx is a clinical knowledge synthesis platform currently in early access. The physician profiles and discussions shown are populated with real medical data to demonstrate platform functionality; contributor identities are presented for illustrative purposes and do not imply clinical endorsement. Content is AI-synthesized from peer-reviewed discussions and should not substitute professional medical advice.
No comments yet. Be the first verified physician to start the discussion.
Verified physicians can comment on published research.
Log in to comment